327.64
price up icon0.10%   0.33
after-market Dopo l'orario di chiusura: 327.40 -0.24 -0.07%
loading
Precedente Chiudi:
$327.31
Aprire:
$328.77
Volume 24 ore:
1.53M
Relative Volume:
0.59
Capitalizzazione di mercato:
$176.43B
Reddito:
$35.89B
Utile/perdita netta:
$7.01B
Rapporto P/E:
25.33
EPS:
12.9352
Flusso di cassa netto:
$11.54B
1 W Prestazione:
-1.59%
1M Prestazione:
-3.17%
6M Prestazione:
+10.37%
1 anno Prestazione:
+26.37%
Intervallo 1D:
Value
$325.01
$329.19
Intervallo di 1 settimana:
Value
$325.01
$333.50
Portata 52W:
Value
$257.05
$346.38

Amgen Inc Stock (AMGN) Company Profile

Name
Nome
Amgen Inc
Name
Telefono
(805)447-1000
Name
Indirizzo
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Name
Dipendente
28,000
Name
Cinguettio
@amgen
Name
Prossima data di guadagno
2025-02-04
Name
Ultimi documenti SEC
Name
AMGN's Discussions on Twitter

Confronta AMGN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - General icon
AMGN
Amgen Inc
327.64 176.25B 35.89B 7.01B 11.54B 12.94
Drug Manufacturers - General icon
LLY
Lilly Eli Co
1,080.36 961.86B 59.42B 18.41B 6.44B 20.22
Drug Manufacturers - General icon
JNJ
Johnson Johnson
207.35 498.60B 92.15B 25.12B 20.46B 10.36
Drug Manufacturers - General icon
ABBV
Abbvie Inc
229.31 403.83B 59.64B 2.36B 19.68B 1.3253
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
138.54 264.54B 54.45B 14.42B 17.15B 7.333
Drug Manufacturers - General icon
MRK
Merck Co Inc
106.45 261.26B 63.90B 19.05B 13.05B 7.5596

Amgen Inc Stock (AMGN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-12-05 Aggiornamento Erste Group Hold → Buy
2025-11-24 Ripresa Truist Hold
2025-11-13 Iniziato Scotiabank Sector Outperform
2025-09-03 Ripresa Raymond James Mkt Perform
2025-05-20 Ripresa Guggenheim Neutral
2025-04-22 Ripresa Cantor Fitzgerald Neutral
2024-12-10 Ripresa BofA Securities Underperform
2024-11-15 Iniziato Wolfe Research Peer Perform
2024-11-14 Iniziato Citigroup Neutral
2024-10-17 Iniziato Bernstein Outperform
2024-10-14 Downgrade Truist Buy → Hold
2024-09-27 Iniziato Cantor Fitzgerald Overweight
2024-08-07 Downgrade Wells Fargo Overweight → Equal Weight
2024-05-03 Aggiornamento Barclays Underweight → Equal Weight
2024-05-03 Aggiornamento William Blair Mkt Perform → Outperform
2024-03-28 Ripresa Raymond James Mkt Perform
2024-02-07 Downgrade Leerink Partners Outperform → Market Perform
2023-12-21 Aggiornamento Daiwa Securities Neutral → Buy
2023-12-19 Aggiornamento BMO Capital Markets Market Perform → Outperform
2023-12-12 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2023-11-09 Iniziato Deutsche Bank Hold
2023-11-02 Aggiornamento Truist Hold → Buy
2023-10-20 Ripresa JP Morgan Neutral
2023-10-17 Ripresa Morgan Stanley Equal-Weight
2023-10-11 Ripresa BofA Securities Neutral
2023-09-06 Iniziato HSBC Securities Buy
2023-04-24 Reiterato Oppenheimer Outperform
2023-03-13 Aggiornamento Wells Fargo Equal Weight → Overweight
2023-02-13 Reiterato Truist Buy
2022-11-18 Iniziato Credit Suisse Underperform
2022-10-31 Downgrade Barclays Equal Weight → Underweight
2022-10-11 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2022-05-23 Iniziato SVB Leerink Mkt Perform
2022-02-09 Reiterato Barclays Equal Weight
2022-02-09 Reiterato Jefferies Buy
2022-02-09 Reiterato Morgan Stanley Equal-Weight
2022-02-09 Reiterato Oppenheimer Outperform
2022-02-09 Reiterato Wells Fargo Equal Weight
2022-01-05 Downgrade BofA Securities Buy → Neutral
2021-12-09 Ripresa Wells Fargo Equal Weight
2021-12-06 Iniziato Goldman Buy
2021-11-19 Iniziato BMO Capital Markets Market Perform
2021-09-23 Downgrade Daiwa Securities Outperform → Neutral
2021-09-07 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-12-29 Iniziato Daiwa Securities Buy
2020-10-28 Iniziato UBS Neutral
2020-10-26 Aggiornamento Raymond James Mkt Perform → Outperform
2020-10-12 Aggiornamento Truist Hold → Buy
2020-10-09 Downgrade Bernstein Outperform → Mkt Perform
2020-10-09 Downgrade Truist Buy → Hold
2020-10-08 Downgrade Raymond James Outperform → Mkt Perform
2020-04-15 Ripresa Guggenheim Neutral
2020-03-31 Iniziato Wolfe Research Peer Perform
2020-03-30 Aggiornamento Raymond James Mkt Perform → Outperform
2020-03-05 Aggiornamento BofA/Merrill Neutral → Buy
2020-02-27 Iniziato Barclays Equal Weight
2020-01-31 Downgrade Robert W. Baird Neutral → Underperform
2020-01-21 Aggiornamento Evercore ISI In-line → Outperform
2019-12-24 Iniziato Raymond James Mkt Perform
2019-12-17 Ripresa Morgan Stanley Overweight
2019-11-12 Iniziato SunTrust Buy
2019-11-05 Aggiornamento Cantor Fitzgerald Neutral → Overweight
2019-10-17 Ripresa BofA/Merrill Neutral
2019-08-19 Downgrade Mizuho Buy → Neutral
2019-05-23 Aggiornamento Citigroup Neutral → Buy
Mostra tutto

Amgen Inc Borsa (AMGN) Ultime notizie

pulisher
Jan 02, 2026

SteelPeak Wealth LLC Sells 52,953 Shares of Amgen Inc. $AMGN - MarketBeat

Jan 02, 2026
pulisher
Jan 02, 2026

Mattern Capital Management LLC Buys 4,411 Shares of Amgen Inc. $AMGN - MarketBeat

Jan 02, 2026
pulisher
Jan 02, 2026

Amgen Inc. $AMGN Shares Sold by Miracle Mile Advisors LLC - MarketBeat

Jan 02, 2026
pulisher
Jan 02, 2026

Pullback Watch: Is Amgen Inc AMG0 stock worth holding before Fed meetingWeekly Trend Recap & Stock Market Timing Techniques - moha.gov.vn

Jan 02, 2026
pulisher
Jan 02, 2026

Braun Stacey Associates Inc. Has $1.27 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat

Jan 02, 2026
pulisher
Jan 01, 2026

Amgen Inc. $AMGN Shares Acquired by Hofer & Associates. Inc - MarketBeat

Jan 01, 2026
pulisher
Jan 01, 2026

VIRGINIA RETIREMENT SYSTEMS ET Al Decreases Stock Holdings in Amgen Inc. $AMGN - MarketBeat

Jan 01, 2026
pulisher
Jan 01, 2026

Amgen Inc. $AMGN Shares Bought by Ascent Group LLC - MarketBeat

Jan 01, 2026
pulisher
Dec 31, 2025

Amgen Inc (TSX:AMGN) Stock News, Headlines & Updates - GuruFocus

Dec 31, 2025
pulisher
Dec 31, 2025

Amgen Inc. $AMGN Shares Acquired by Calamos Wealth Management LLC - MarketBeat

Dec 31, 2025
pulisher
Dec 31, 2025

Boston Trust Walden Corp Lowers Holdings in Amgen Inc. $AMGN - MarketBeat

Dec 31, 2025
pulisher
Dec 30, 2025

Amgen (AMGN): Buy, Sell, or Hold Post Q3 Earnings? - TradingView — Track All Markets

Dec 30, 2025
pulisher
Dec 30, 2025

Strong Results and Pipeline Momentum Power Amgen's (AMGN) 2025 Rally - Finviz

Dec 30, 2025
pulisher
Dec 30, 2025

Strong Results and Pipeline Momentum Power Amgen’s (AMGN) 2025 Rally - Insider Monkey

Dec 30, 2025
pulisher
Dec 30, 2025

Amgen stock dips as Lumakras combo trial ends; MariTide data now the next watch - ts2.tech

Dec 30, 2025
pulisher
Dec 30, 2025

Can Amgen's MariTide Take on Leaders in the Obesity Space? - The Globe and Mail

Dec 30, 2025
pulisher
Dec 30, 2025

Argus Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock - MarketBeat

Dec 30, 2025
pulisher
Dec 30, 2025

Argus Adjusts Price Target on Amgen to $360 From $310, Maintains Buy Rating - marketscreener.com

Dec 30, 2025
pulisher
Dec 30, 2025

Diversified Trust Co Has $12.05 Million Stock Position in Amgen Inc. $AMGN - MarketBeat

Dec 30, 2025
pulisher
Dec 30, 2025

The Truth About Amgen Inc.: Is This Biotech Giant the Next Big Money Gamechanger? - AD HOC NEWS

Dec 30, 2025
pulisher
Dec 30, 2025

Amgen Inc.: How a Biotech Veteran Is Rebuilding Its Flagship Pipeline - AD HOC NEWS

Dec 30, 2025
pulisher
Dec 29, 2025

Amgen stock slips to $330 as year-end pullback hits Wall Street; Fed minutes and MariTide updates in focus - ts2.tech

Dec 29, 2025
pulisher
Dec 29, 2025

Strong results and pipeline momentum power Amgen’s (AMGN) 2025 rally - MSN

Dec 29, 2025
pulisher
Dec 29, 2025

Verastem ends trial of Avmapki Fakzynja combo with Amgen's Lumakras in NSCLC - Seeking Alpha

Dec 29, 2025
pulisher
Dec 29, 2025

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Dec 29, 2025
pulisher
Dec 29, 2025

Amgen Inc. $AMGN Shares Acquired by SS&H Financial Advisors Inc. - MarketBeat

Dec 29, 2025
pulisher
Dec 27, 2025

Amgen Inc. Stock (AMGN) Opinions on 2025 Revenue Guidance and Drug Sales - Quiver Quantitative

Dec 27, 2025
pulisher
Dec 27, 2025

Amgen Inc. $AMGN Shares Sold by Meyer Handelman Co. - MarketBeat

Dec 27, 2025
pulisher
Dec 27, 2025

Carnegie Investment Counsel Has $30.27 Million Stake in Amgen Inc. $AMGN - MarketBeat

Dec 27, 2025
pulisher
Dec 26, 2025

Can Amgen Sustain Its Rally In 2026 (NASDAQ:AMGN) - Seeking Alpha

Dec 26, 2025
pulisher
Dec 26, 2025

Check out Amgen's stock price (AMGN-CA) in real time - CNBC

Dec 26, 2025
pulisher
Dec 26, 2025

Amgen Inc. $AMGN Stake Reduced by Pacer Advisors Inc. - MarketBeat

Dec 26, 2025
pulisher
Dec 26, 2025

Avanza Fonder AB Purchases 4,546 Shares of Amgen Inc. $AMGN - MarketBeat

Dec 26, 2025
pulisher
Dec 25, 2025

Does FDA’s UPLIZNA gMG Expansion Reshape the Bull Case for Amgen’s Diversification Story (AMGN)? - simplywall.st

Dec 25, 2025
pulisher
Dec 25, 2025

Brookstone Capital Management Acquires 16,042 Shares of Amgen Inc. $AMGN - MarketBeat

Dec 25, 2025
pulisher
Dec 25, 2025

Farther Finance Advisors LLC Buys 3,158 Shares of Amgen Inc. $AMGN - MarketBeat

Dec 25, 2025
pulisher
Dec 25, 2025

Amgen Inc. $AMGN Shares Sold by Alpine Woods Capital Investors LLC - MarketBeat

Dec 25, 2025
pulisher
Dec 24, 2025

Amgen Strikes Drug Pricing Deal With Trump: What Investors Should Know - The Globe and Mail

Dec 24, 2025
pulisher
Dec 24, 2025

Swedbank AB Sells 283,479 Shares of Amgen Inc. $AMGN - MarketBeat

Dec 24, 2025
pulisher
Dec 24, 2025

Should You Be Excited About Amgen Inc.'s (NASDAQ:AMGN) 73% Return On Equity? - Yahoo Finance

Dec 24, 2025
pulisher
Dec 24, 2025

Amgen Inc. $AMGN Shares Bought by Global X Japan Co. Ltd. - MarketBeat

Dec 24, 2025
pulisher
Dec 23, 2025

Novo Nordisk vs. Amgen: Which Healthcare Stock Is the Smarter Choice? - The Globe and Mail

Dec 23, 2025
pulisher
Dec 23, 2025

Revolve Wealth Partners LLC Sells 12,066 Shares of Amgen Inc. $AMGN - MarketBeat

Dec 23, 2025
pulisher
Dec 23, 2025

Exchange Traded Concepts LLC Has $17.78 Million Position in Amgen Inc. $AMGN - MarketBeat

Dec 23, 2025
pulisher
Dec 23, 2025

Is There Still Value in Amgen After Its Strong 2025 Share Price Run? - simplywall.st

Dec 23, 2025
pulisher
Dec 22, 2025

Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know - sharewise.com

Dec 22, 2025
pulisher
Dec 22, 2025

Amgen Stock After Hours (AMGN) on Dec. 22, 2025: FDA Clears New Prolia/Xgeva Biosimilars, Fitch Upgrades Credit — What to Know Before the Dec. 23 Open - ts2.tech

Dec 22, 2025
pulisher
Dec 22, 2025

Fitch upgrades Amgen to ’BBB+’ on improved financial structure By Investing.com - Investing.com Nigeria

Dec 22, 2025
pulisher
Dec 22, 2025

Fitch upgrades Amgen to ’BBB+’ on improved financial structure - Investing.com

Dec 22, 2025
pulisher
Dec 22, 2025

Fitch raises Amgen credit rating, outlook stable - breakingthenews.net

Dec 22, 2025
pulisher
Dec 22, 2025

Our Workforce - Amgen

Dec 22, 2025

Amgen Inc Azioni (AMGN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$121.60
price down icon 0.93%
drug_manufacturers_general PFE
$25.18
price up icon 1.12%
drug_manufacturers_general NVO
$52.39
price up icon 2.97%
drug_manufacturers_general SNY
$48.23
price down icon 0.47%
drug_manufacturers_general MRK
$106.45
price up icon 1.13%
Capitalizzazione:     |  Volume (24 ore):